Catcha Investment Corp: Nasdaq/NYSE listing notice — Catcha Investment Corp receives NYSE American delisting notice for late Form 10-K filing

Catcha Investment Corp

Notice received April 17, 2024 for failure to timely file 2023 Form 10-K by the April 16, 2024 deadline.
Company has a six-month Initial Cure Period (until Oct 16, 2024) to file the Form 10-K with the SEC.
If not cured, NYSE American may grant an additional six-month cure period at its sole discretion.
Company previously filed Form 12b-25 on April 2, 2024 indicating delay; needs more time to finalize financial statements.
Listing on NYSE American not immediately affected; no assurance of regaining compliance.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Catcha Investment Corp received a nyse_american deficiency notice notice regarding late filing (rules 1007).

Exchange: nyse american
Notice: deficiency notice
Deficiency: late filing
Rules: 1007

Exact text from the filing

April 17, 2024, Catcha Investment Corp (the “Company”) received a written notice (the “Notice”) from New York Stock Exchange Regulation, Inc. indicating that the Company was not in compliance with NYSE American’s continued listing standards because the Company did not timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”), which was due on April 16, 2024. In accordance with Section 1007 of the NYSE American Company Guide, the Company will have six months from April 16, 2024 (the “Initial Cure Period”), to file the Form 10-K with the Securities

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-24-035374

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.